BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35912635)

  • 21. The associations between TMAO-related metabolites and blood lipids and the potential impact of rosuvastatin therapy.
    Xiong X; Zhou J; Fu Q; Xu X; Wei S; Yang S; Chen B
    Lipids Health Dis; 2022 Jul; 21(1):60. PubMed ID: 35864500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRIMETHYLAMINE OXIDE - FACTOR IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND A POTENTIAL TARGET FOR DIETARY AND PHARMACOLOGICAL INTERVENTIONS.
    Olma A; Streb W; Lazar M
    Pol Merkur Lekarski; 2023; 51(1):54-58. PubMed ID: 36960901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.
    Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL
    J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In older women, a high-protein diet including animal-sourced foods did not impact serum levels and urinary excretion of trimethylamine-N-oxide.
    Dahl WJ; Hung WL; Ford AL; Suh JH; Auger J; Nagulesapillai V; Wang Y
    Nutr Res; 2020 Jun; 78():72-81. PubMed ID: 32544852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten-year changes in plasma L-carnitine levels and risk of coronary heart disease.
    Heianza Y; Ma W; DiDonato JA; Sun Q; Rimm EB; Hu FB; Rexrode KM; Manson JE; Qi L
    Eur J Nutr; 2022 Apr; 61(3):1353-1362. PubMed ID: 34799774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consumption of Meat, Fish, Dairy Products, and Eggs and Risk of Ischemic Heart Disease.
    Key TJ; Appleby PN; Bradbury KE; Sweeting M; Wood A; Johansson I; Kühn T; Steur M; Weiderpass E; Wennberg M; Lund Würtz AM; Agudo A; Andersson J; Arriola L; Boeing H; Boer JMA; Bonnet F; Boutron-Ruault MC; Cross AJ; Ericson U; Fagherazzi G; Ferrari P; Gunter M; Huerta JM; Katzke V; Khaw KT; Krogh V; La Vecchia C; Matullo G; Moreno-Iribas C; Naska A; Nilsson LM; Olsen A; Overvad K; Palli D; Panico S; Molina-Portillo E; Quirós JR; Skeie G; Sluijs I; Sonestedt E; Stepien M; Tjønneland A; Trichopoulou A; Tumino R; Tzoulaki I; van der Schouw YT; Verschuren WMM; di Angelantonio E; Langenberg C; Forouhi N; Wareham N; Butterworth A; Riboli E; Danesh J
    Circulation; 2019 Jun; 139(25):2835-2845. PubMed ID: 31006335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
    Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M
    Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
    Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
    Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts.
    Nanna MG; Navar AM; Wojdyla D; Peterson ED
    J Am Geriatr Soc; 2019 Dec; 67(12):2560-2567. PubMed ID: 31411740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary Levels of Trimethylamine-N-Oxide and Incident Coronary Heart Disease: A Prospective Investigation Among Urban Chinese Adults.
    Yu D; Shu XO; Rivera ES; Zhang X; Cai Q; Calcutt MW; Xiang YB; Li H; Gao YT; Wang TJ; Zheng W
    J Am Heart Assoc; 2019 Jan; 8(1):e010606. PubMed ID: 30606084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
    Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red meat intake and risk of coronary heart disease among US men: prospective cohort study.
    Al-Shaar L; Satija A; Wang DD; Rimm EB; Smith-Warner SA; Stampfer MJ; Hu FB; Willett WC
    BMJ; 2020 Dec; 371():m4141. PubMed ID: 33268459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of Social Disadvantage Score in Cardiovascular Outcomes and Risk Assessment: Findings From the Multi-Ethnic Study of Atherosclerosis.
    Hammoud A; Chen H; Ivanov A; Yeboah J; Nasir K; Cainzos-Achirica M; Bertoni A; Khan SU; Blaha M; Herrington D; Shapiro MD
    Circ Cardiovasc Qual Outcomes; 2023 Jul; 16(7):e009304. PubMed ID: 37403692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
    Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
    Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis.
    Cardona A; O'Brien A; Bernier MC; Somogyi A; Wysocki VH; Smart S; He X; Ambrosio G; Hsueh WA; Raman SV
    BMJ Open Diabetes Res Care; 2019; 7(1):e000718. PubMed ID: 31798892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inverted U-Shaped Association of Plasma Resolvin D2 With Atherosclerotic Cardiovascular Disease and the Mediation Effects of Serum Cholesterol: A Chinese Community-Based Study.
    Liu B; Zhang J; Zhang K; Li M; Jing Y; Gu S; Ding H; Liang Y; Zhou H; Dong C
    J Am Heart Assoc; 2024 Mar; 13(5):e032588. PubMed ID: 38420767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort.
    Byrd DA; Zouiouich S; Karwa S; Li XS; Wang Z; Sampson JN; Loftfield E; Huang WY; Hazen SL; Sinha R
    Cancer; 2024 Jun; 130(11):1982-1990. PubMed ID: 38285606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease.
    Al Samarraie A; Pichette M; Rousseau G
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between diseases of despair and atherosclerotic cardiovascular disease among insured adults in the USA: a retrospective cohort study from 2017 to 2021.
    Nudy M; Galper K; George DR; Williams BA; Kraschnewski JL; Sinoway L; Brignone E
    BMJ Open; 2023 Sep; 13(9):e074102. PubMed ID: 37673458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.